Focus on the development and commercialization of new drugs for perioperative anesthesia, analgesia, anti-inflammation and anti-infectiion.

Cali Biosciences

We are an international biopharmaceutical company dedicated to the research and development of innovative drugs. We have several patented technology platforms and an international team of scientific research and management talents. We focus on the R&D of perioperative drugs. The product pipeline includes new drugs in the fields of anesthesia, analgesia, anti-inflammatory and anti-infection. In the future, we will also promote the commercialization of products to fully respond to the unmet market demand.


R&D PipelineCali Biosciences has built a pipeline of products including multiple drug candidates.


Technology platformCali Biosciences possesses multiple patented drug delivery technology platforms.


R&D CenterThe drug R&D center of Cali Biosciences focuses on the research of complex formulations of perioperative drugs.



ASRA 2021 | Cali Biosciences Presents Phase IIa Clinical ...

SAN DIEGO, Nov. 19, 2021 /PRNewswire/ -- Cali Biosciences, a global biopharmaceutical company focused on the research an...

Cali Biosciences Initiates Phase 2b Study of Long-Acting Ropi...

SAN DIEGO, Aug. 11, 2021 /PRNewswire/ -- Cali Biosciences Co., Ltd. (hereinafter referred to as "CaliBio"), a global biopharmaceu...